Navigation Links
Stem cells from brain transformed to produce insulin at Stanford

With careful coaxing, stem cells from the brain can form insulin-producing cells that mimic those missing in people with diabetes, according to a paper published in the April 26 issue of PLoS Medicine.

Although the work is not yet ready for human patients, Seung Kim, MD, PhD, the lead author and assistant professor of developmental biology at the Stanford University School of Medicine, said it could lead to new ways of transplanting insulin-producing cells into people with diabetes, eventually providing a cure for the disease.

In past work, Kim and members of his lab enticed mouse embryonic stem cells to transform into insulin-producing cells. When transplanted into diabetic mice, these cells effectively made up for the lost insulin-producing cells in the pancreas, called islet cells, and treated the diabetes. However, embryonic stem cells are difficult to work with in the lab and most existing human embryonic stem cell lines are contaminated and can't be transplanted into humans.

Kim thought that human neural stem cells may be one way to sidestep the more problematic embryonic stem cells. The study shows that his intuition was correct.

"When you look at islets cells you realize that they resemble neurons," Kim said. Like neurons, islet cells respond to external signals by changing their electrical properties and releasing packages of proteins. In the case of islets, that protein is insulin.

What's more, some neurons in mice and humans take the first steps toward producing insulin. In insects such as fruit flies, the cells that produce insulin and regulate blood sugar are, in fact, neurons. Taken together, this evidence suggested to Kim that neural stem cells may be able to produce insulin.

Despite Kim's informed hunch, the fact that it worked is a bit surprising.

Until recently, people had though that stem cells taken from the brain would only be able to transform into brain-related tissues such as nerves and s
'"/>

Source:Stanford University Medical Center


Page: 1 2 3

Related biology news :

1. Wisconsin scientists grow critical nerve cells
2. Spleen may be source of versatile stem cells
3. Researchers discover way to make cells in the eye sensitive to light
4. Priming embryonic stem cells to fulfill their promise
5. Lack of enzyme turns fat cells into fat burners
6. Poor prenatal nutrition permanently damages function of insulin-producing cells in the pancreas
7. Elusive HIV shape change revealed; Key clue to how virus infects cells
8. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
9. Enzyme allows B cells to resist death, leading to leukemia
10. Scientists rid stem cell culture of key animal cells
11. Genetically modified natural killer immune cells attack, kill leukemia cells
Post Your Comments:
(Date:7/25/2008)...e basic science discoveries into the clinical aren...rs at the Medical College of Wisconsin, in Milwauk...fied reasons why clinical science grant applicati...science grant applications to the NIH. The finding...n Journal of Medicine . , In collaboration with ...
(Date:7/25/2008)...try specialists from 22 countries are sharing the ..., such as mustard, radish, or rapeseed, to manage ...iofumigation. ," Brassica plants naturally rele...rincipally isothiocyanates (ITCs), which most peop... or horseradish," says CSIRO,s Dr John Kirkegaard....
(Date:7/25/2008)...en, can potentially contain a naturally occurring ...o public health according to a review paper publis...f the Science of Food and Agriculture (JSFA). , ...green, affected area is enough to eliminate most o...suggests that the levels of GA in potatoes can be ...
(Date:7/24/2008)... by Massachusetts General Hospital (MGH) investiga... research and medicine a robust method for genera...DNA sequences for inactivation or repair. In the...s describe an efficient, publicly available method...s), which can be used to induce specific genomic m...
Breaking Biology News(10 mins):New study spotlights National Institutes of Health grant outcomes for clinical research 2Consortium develops new method enabling routine targeted gene modification 2ADVENTRX Pharmaceuticals Inc Reports Fourth Quarter and Full Year 2007 Financial Results 3948 1ADVENTRX Pharmaceuticals Inc Reports Fourth Quarter and Full Year 2007 Financial Results 3948 2ADVENTRX Pharmaceuticals Inc Reports Fourth Quarter and Full Year 2007 Financial Results 3948 3ADVENTRX Pharmaceuticals Inc Reports Fourth Quarter and Full Year 2007 Financial Results 3948 4ADVENTRX Pharmaceuticals Inc Reports Fourth Quarter and Full Year 2007 Financial Results 3948 5ADVENTRX Pharmaceuticals Inc Reports Fourth Quarter and Full Year 2007 Financial Results 3948 6ADVENTRX Pharmaceuticals Inc Reports Fourth Quarter and Full Year 2007 Financial Results 3948 7FDA Panel Supports Anemia Drugs for Cancer Patients 14341 1FDA Panel Supports Anemia Drugs for Cancer Patients 14341 2FDA Panel Supports Anemia Drugs for Cancer Patients 14341 3SURGEX 28TM 29 Joins the Team of Sponsors for the PGA Tours 2008 Arnold Palmer Invitational Presented by MasterCard 14337 1SURGEX 28TM 29 Joins the Team of Sponsors for the PGA Tours 2008 Arnold Palmer Invitational Presented by MasterCard 14337 2SURGEX 28TM 29 Joins the Team of Sponsors for the PGA Tours 2008 Arnold Palmer Invitational Presented by MasterCard 14337 3SURGEX 28TM 29 Joins the Team of Sponsors for the PGA Tours 2008 Arnold Palmer Invitational Presented by MasterCard 14337 4ViroPharma to Present at the Cowen 26 Company 28th Annual Healthcare Conference 3947 1
...gets wiser, so do the bugs. The rates of drug-resi... and in the hospital have been increasing steadily...the June 15 issue of Clinical Infectious Diseases,...rganisms has become a problem due in part to inapp...hese drug-resistant "superbugs" can infect people ...
...scientist at Washington University in St. Louis ha...nome of a worm and has found 150 genes that were m...r, using the software, he and his colleagues have ...ing 1119 more genes. , Michael Brent, Ph.D., Washi... engineering, used his unique software, TWINSCAN, ...
...impact factors prove that BioMed Central,s Open Ac... cited. Journals published by BioMed Central have ...th equivalent subscription titles, it was announce... specialty. The high impact factors for these jour..., and are fast becoming the place for authors to s...
...s are active protein polymers critical to the stru...l division. In a living cell their growing ends co...y of polymerization and depolymerization, like the...ly as "dynamic instability," this ongoing rapid gr...of microtubules in the cell. , For the first time,...
Other Biology News:Two studies document rise of superbugs in the environment 2Two studies document rise of superbugs in the environment 3Program finds lost genes in nematode genome 2Program finds lost genes in nematode genome 3Open Access journals get impressive impact factors 2The making and breaking of microtubules 2The making and breaking of microtubules 3The making and breaking of microtubules 4The making and breaking of microtubules 5
(Date:7/24/2008)...ly 24 /- The Global Probiotics Counci... DANONE and Yakult Honsha,Co., Ltd., announced the...,Investigator Grant for Probiotics Research (YIGPR...g rising stars who will continue to contribute to,...esearch in the United,States., Ajay S. Gulati, MD...
(Date:7/24/2008)..., Calif., July 24 /- Poniar...rmaceutical company focused,on oncology, today ann...uss,the Company,s second quarter results and provi...clinical development plan for picoplatin, the,Comp..., chairman and chief,executive officer, Ronald A. ...
(Date:7/24/2008)...y 24 /- Cara Therapeutics, Inc.,annou...additional funding,to its original $24 million Ser...ound was led by new investor, Devon Park Bioventur...vations. Previous investors participating,in the r...shi International,Corporation and Wistar Morris. I...
(Date:7/24/2008)...uly 24 /- Sagent Pharmaceuticals, Inc...ny, today announced that it,has launched ceftazidi...rum, beta-lactam antibiotic. Sagent will offer cef...macy bulk package vials. According to,IMS data, 20...ates were,approximately $45.7 million., "Sagent i...
Breaking Biology Technology:Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 2Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 3Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 4Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31 2Cara Therapeutics Secures $12.3 Million in Series C Extension Financing 2Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP 2
...r network Silicon Pastures will invest $195,000 ...oping a next-generation credit card processor that...usual for Wisconsin-based investors to look beyond...director of Silicon Pastures, said this investment...right place. , ,"Our investors traditionally pref...
... of a U.S. Senate debate on stem cell policy just ... Senators to overturn President Bush,s ban on fe...,During a morning visit to the West Salem home of ...n Adam has diabetes, Doyle again used the backdrop...stem cell research to plead his case for a less re...
...n of NeoClone secured equity money early this ye...mitment to his investors to take a more aggressive...a seven-year-old manufacturer of monoclonal antibo...base organically, through word-of mouth, and by us...he had to do more to maximize his relatively small...
...the medical device developer that has secured $42 ...les of its precision radiation therapy technology ...in-Madison researchers, is riding high. , ,So hig..., ,The company, which recently completed an $8.2 m...production and test volumes, has no immediate need...
Other Biology Technology:Doyle urges Senate to loosen stem cell restrictions 2Doyle urges Senate to loosen stem cell restrictions 3Doyle urges Senate to loosen stem cell restrictions 4Can sales outsourcing grow Wisconsin biotechs? 2Can sales outsourcing grow Wisconsin biotechs? 3Cash-rich TomoTherapy has no plans for IPO 2Cash-rich TomoTherapy has no plans for IPO 3Cash-rich TomoTherapy has no plans for IPO 4
Lingo-1 (K-13)
Rabbit polyclonal to Atrophin 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide conjugated to KLH derived from within residues 1150 to the C-terminus of Human Atrophin 1.(No
Monoclonal 8C2.1 is specific for Bunyavirus G1 as tested by neutralization, immunoprecipitation and immunobinding assays.
Complexin-1/2 (FL-134)
Biology Products: